Browsing Tag
Non-life Insurance
Rail Shippers Brace for Potential National Strike
Companies from food suppliers in the Midwest to retail importers across the U.S. are bracing for a potential national rail strike by seeking alternative transport to keep their supply chains…
UnitedHealth CFO Added to Lawsuit Over 401(k) Offerings
UnitedHealth
Group Inc.’s finance chief allegedly put business interests first and ignored information that the company’s 401(k) plan was filled with…
Housing-Affordability Index Drops to Lowest Level Since 2006
Record home prices and higher mortgage rates in May made it the most expensive month since 2006 to buy a home, prompting more buyers to give up and pressuring sellers to cut asking…
Anthem Looks to Fuel AI Efforts With Petabytes of Synthetic Data
Anthem Inc.’s
chief information officer says he is working with
Alphabet Inc.’s
Google Cloud to create a…
WSJ News Exclusive | Hospitals Look to Raise Treatment Costs as Nurses’ Salaries…
Some hospitals grappling with rising nurse salaries are seeking to raise prices by up to 15%, touching off contract fights with health insurers and businesses and threatening higher…
Millions of Americans Are Turning to Therapy, and Investors See an Opportunity
Psychiatrists and psychologists once ran their own practices. Now the local therapist office could be controlled by a buyout king.Venture capitalists and private-equity firms are pouring…
Health segment perks up non-life insurers’ FY22 show
Standalone private health insurers saw a 32.5% rise in premium to ₹20,880 crore
Standalone private health insurers saw a 32.5% rise in premium to ₹20,880 crore
Non-life insurers clocked an…
Drugmakers Raised Prices by 6.6% on Average Early This Year
Drugmakers raised list prices by an average of 6.6% in the first few weeks of this year on cancer, diabetes and other prescription medicines, sticking with more moderate increases while…
Medicare to Pay for Biogen’s New Alzheimer’s Drug in Clinical-Trial Patients
Medicare officials said they would cover
Biogen Inc.’s
BIIB 2.64%
controversial Alzheimer’s disease drug Aduhelm on the condition that…